Metabolic Crossroads: Decoding the Immune-Tumor Interface for Therapeutic Breakthroughs

The interface between the immune system and tumor cells plays a crucial role in determining the progression and treatment of cancer. Recent research has highlighted the metabolic crossroads at this interface, where both immune and tumor cells undergo dynamic metabolic reprogramming in response to their microenvironment. Tumor cells often alter their metabolic pathways to support rapid growth and survival, while immune cells, particularly T-cells, exhibit metabolic shifts that influence their ability to recognize and eliminate tumor cells.



This emerging field seeks to unravel the complex metabolic interactions between tumor cells and immune cells, with a focus on how these changes contribute to tumor progression, immune evasion, and resistance to therapy. By understanding the metabolic processes at play, new therapeutic strategies can be developed to manipulate these pathways, either by restoring immune function or by targeting the metabolic vulnerabilities of tumors. Such therapeutic breakthroughs could offer more effective, personalized approaches to cancer treatment, particularly in immunotherapy and targeted therapies.



In summary, the concept of metabolic crossroads emphasizes the need for integrated approaches to cancer therapy that consider both metabolic and immune factors. Decoding these pathways holds great promise for the development of next-generation cancer treatments that enhance immune responses and overcome therapeutic resistance.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Data Report
• Editorial
• FAIR² Data
• FAIR² DATA Direct Submission
• General Commentary
• Hypothesis and Theory
• Methods
• Mini Review
• ... View all formats

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Data Report
• Editorial
• FAIR² Data
• FAIR² DATA Direct Submission
• General Commentary
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• Original Research
• Perspective
• Review
• Technology and Code

Keywords: Immune-tumor interface Metabolic reprogramming Tumor microenvironment Immune evasion Cancer immunotherapy Metabolic pathways Therapy resistance

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.